Institutional Fund
Foresite Capital Management IV, LLC
West Hollywood, CACIK 17041325 filings on record
Portfolio Value
$237.08M
Q1 2026
Holdings
8
Reported positions
New Buys
1
Opened this quarter
QoQ Change
+3.2%
from $229.71M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Pharvaris N V56.9%
- Cytokinetics Inc14.0%
- Eikon Therapeutics Inc8.7%
- Lyell Immunopharma Inc6.8%
- Relay Therapeutics Inc4.2%
- Xenon Pharmaceuticals Inc3.9%
- Other5.5%
Portfolio Holdings
8 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Pharvaris N V | 4.78M | $134.99M | 56.9% | 0 | Held |
| 2 | Cytokinetics Inc | 503.3K | $33.17M | 14.0% | +45.0K | Added |
| 3 | Eikon Therapeutics Inc | 1.94M | $20.56M | 8.7% | +1.94M | New |
| 4 | Lyell Immunopharma Inc | 800.4K | $16.06M | 6.8% | 0 | Held |
| 5 | Relay Therapeutics Inc | 1.00M | $9.95M | 4.2% | 0 | Held |
| 6 | Xenon Pharmaceuticals Inc | 160.0K | $9.30M | 3.9% | 0 | Held |
| 7 | Alector Inc | 3.89M | $8.36M | 3.5% | 0 | Held |
| 8 | Maze Therapeutics Inc | 156.9K | $4.68M | 2.0% | −365.8K | Reduced |